Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
DNA LandMarks is a Canadian biotechnology company specializing in high-throughput DNA sequencing and genotyping services, primarily for the agricultural sector. Founded in 1995 and headquartered in Saint-Jean-sur-Richelieu, Quebec, the company serves as a global "Centre of Excellence" for genomics within the BASF Group. It provides a wide range of services including DNA marker development, genetic mapping, and molecular characterization to support plant breeding and crop improvement. Since its acquisition by BASF Plant Science in 1999, DNA LandMarks has combined its expertise in plant genetics with BASF's global infrastructure to serve clients in the seed and biotechnology industries worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on International DNA Landmarks.